[PTGX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
10-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -143.28%
YoY- -7.91%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 10,286 2,265 6,189 5,650 13,114 6,217 3,647 99.49%
PBT -33,804 -30,842 -23,998 -18,886 -7,763 -18,292 -19,904 42.30%
Tax 122 -57 -79 -1,305 -40 1,129 176 -21.65%
NP -33,804 -30,842 -23,998 -18,886 -7,763 -19,421 -20,080 41.47%
Tax Rate - - - - - - - -
Total Cost 44,090 33,107 30,187 24,536 20,877 25,638 23,727 51.08%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -328.64 -1,361.68 -387.75 -334.27 -59.20 -312.39 -550.59 -29.08%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.70 -0.69 -0.54 -0.48 -0.21 -0.59 -0.72 -1.85%
EPS Diluted -0.70 -0.69 -0.54 -0.48 -0.21 -0.59 -0.72 -1.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.